An epidemiological survey of Raynaud's phenomenon

A questionnaire was sent to 1000 patients with Raynaud's phenomenon (RP) and an equal number of controls in order to accumulate one of the largest patient data banks currently available. Five-hundred and seventy-one correctly completed paired returns were processed so as to investigate the asso...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of vascular surgery 1988-06, Vol.2 (3), p.167-170
Hauptverfasser: de Trafford, J.C., Lafferty, K., Potter, C.E., Roberts, V.C., Cotton, L.T.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 170
container_issue 3
container_start_page 167
container_title European journal of vascular surgery
container_volume 2
creator de Trafford, J.C.
Lafferty, K.
Potter, C.E.
Roberts, V.C.
Cotton, L.T.
description A questionnaire was sent to 1000 patients with Raynaud's phenomenon (RP) and an equal number of controls in order to accumulate one of the largest patient data banks currently available. Five-hundred and seventy-one correctly completed paired returns were processed so as to investigate the association between Raynaud's phenomenon and other factors suspected of influencing the condition. The involvement of female sex hormones in RP was indicated by the predominance of women (93%), a 6% (P < 0.02) higher incidence of infertility and the influence of menstruation (15%), the menopause (73%) and pregnancy (53%) on symptoms. Patients with scleroderma had a 5% higher incidence of stillbirths. A familial predisposition for RP was noted dependent on age at onset of symptoms (age < 30, 14% > 30, 4.9%). The Raynaud's group overall had a significantly higher percentage who had been treated for migraine (7% higher P < 0.01), angina (3% higher P < 0.05) and duodenal ulcer (3% higher P < 0.001). Of the respondents who had undergone sympathectomy (n = 140, 24.5% of the total), 18.6% claimed lasting benefit and 66.4% claimed no benefit after one year. The mean age at sympathectomy was 38.6 years ( s.d. ± 13 range 14–78) with a mean age of start of symptoms of 29.2 years ( s.d. ± 14.7, range 0–70). There was no significant difference between the effects of sympathectomy on those patients with and those without associated conditions.
doi_str_mv 10.1016/S0950-821X(88)80070-7
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78376029</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0950821X88800707</els_id><sourcerecordid>78376029</sourcerecordid><originalsourceid>FETCH-LOGICAL-c275t-bdff08dbb95076666c5f3521802bc0a8198efe89ddd535e49b2f7104450a34ad3</originalsourceid><addsrcrecordid>eNqFkMlqwzAQhnVoSdO0jxDwqcvB7ci2LPlUQugGgUIX6E3I0rhVsS1XigN5-zoLuXZgGJjtn_kImVK4oUDz2zcoGMQioZ9XQlwLAA4xPyLjQ_qEnIbwA5DyApIRGaUZBcjZmNBZG2FnDTbW1e7LalVHofcrXEeuil7VulW9uQxR942tawZvz8hxpeqA5_s4IR8P9-_zp3jx8vg8ny1inXC2jEtTVSBMWQ4n8HwwzaqUJVRAUmpQghYCKxSFMYalDLOiTCpOIcsYqDRTJp2Qi93ezrvfHsNSNjZorGvVouuD5CLlOSTF0Mh2jdq7EDxWsvO2UX4tKcgNHrnFIzccpBByi0fyYW66F-jLBs1has9mqN_t6jh8ubLoZdAWW43GetRLaZz9R-EPHVh2Rw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78376029</pqid></control><display><type>article</type><title>An epidemiological survey of Raynaud's phenomenon</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>de Trafford, J.C. ; Lafferty, K. ; Potter, C.E. ; Roberts, V.C. ; Cotton, L.T.</creator><creatorcontrib>de Trafford, J.C. ; Lafferty, K. ; Potter, C.E. ; Roberts, V.C. ; Cotton, L.T.</creatorcontrib><description>A questionnaire was sent to 1000 patients with Raynaud's phenomenon (RP) and an equal number of controls in order to accumulate one of the largest patient data banks currently available. Five-hundred and seventy-one correctly completed paired returns were processed so as to investigate the association between Raynaud's phenomenon and other factors suspected of influencing the condition. The involvement of female sex hormones in RP was indicated by the predominance of women (93%), a 6% (P &lt; 0.02) higher incidence of infertility and the influence of menstruation (15%), the menopause (73%) and pregnancy (53%) on symptoms. Patients with scleroderma had a 5% higher incidence of stillbirths. A familial predisposition for RP was noted dependent on age at onset of symptoms (age &lt; 30, 14% &gt; 30, 4.9%). The Raynaud's group overall had a significantly higher percentage who had been treated for migraine (7% higher P &lt; 0.01), angina (3% higher P &lt; 0.05) and duodenal ulcer (3% higher P &lt; 0.001). Of the respondents who had undergone sympathectomy (n = 140, 24.5% of the total), 18.6% claimed lasting benefit and 66.4% claimed no benefit after one year. The mean age at sympathectomy was 38.6 years ( s.d. ± 13 range 14–78) with a mean age of start of symptoms of 29.2 years ( s.d. ± 14.7, range 0–70). There was no significant difference between the effects of sympathectomy on those patients with and those without associated conditions.</description><identifier>ISSN: 0950-821X</identifier><identifier>DOI: 10.1016/S0950-821X(88)80070-7</identifier><identifier>PMID: 3410065</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Adolescent ; Adult ; Age Factors ; Aged ; Aged, 80 and over ; Angina Pectoris - epidemiology ; Child ; Epidemiology ; Female ; Fetal Death - complications ; Health Surveys ; Humans ; Infertility - epidemiology ; Male ; Menopause ; Menstrual Cycle ; Middle Aged ; Migraine Disorders - epidemiology ; Pre-Eclampsia - epidemiology ; Pregnancy ; Raynaud Disease - complications ; Raynaud Disease - epidemiology ; Raynaud Disease - therapy ; Raynaud's phenomenon ; Scleroderma ; Scleroderma, Systemic - complications ; Surveys and Questionnaires ; Sympathectomy</subject><ispartof>European journal of vascular surgery, 1988-06, Vol.2 (3), p.167-170</ispartof><rights>1988 Grune &amp; Stratton Ltd</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c275t-bdff08dbb95076666c5f3521802bc0a8198efe89ddd535e49b2f7104450a34ad3</citedby><cites>FETCH-LOGICAL-c275t-bdff08dbb95076666c5f3521802bc0a8198efe89ddd535e49b2f7104450a34ad3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3410065$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>de Trafford, J.C.</creatorcontrib><creatorcontrib>Lafferty, K.</creatorcontrib><creatorcontrib>Potter, C.E.</creatorcontrib><creatorcontrib>Roberts, V.C.</creatorcontrib><creatorcontrib>Cotton, L.T.</creatorcontrib><title>An epidemiological survey of Raynaud's phenomenon</title><title>European journal of vascular surgery</title><addtitle>Eur J Vasc Surg</addtitle><description>A questionnaire was sent to 1000 patients with Raynaud's phenomenon (RP) and an equal number of controls in order to accumulate one of the largest patient data banks currently available. Five-hundred and seventy-one correctly completed paired returns were processed so as to investigate the association between Raynaud's phenomenon and other factors suspected of influencing the condition. The involvement of female sex hormones in RP was indicated by the predominance of women (93%), a 6% (P &lt; 0.02) higher incidence of infertility and the influence of menstruation (15%), the menopause (73%) and pregnancy (53%) on symptoms. Patients with scleroderma had a 5% higher incidence of stillbirths. A familial predisposition for RP was noted dependent on age at onset of symptoms (age &lt; 30, 14% &gt; 30, 4.9%). The Raynaud's group overall had a significantly higher percentage who had been treated for migraine (7% higher P &lt; 0.01), angina (3% higher P &lt; 0.05) and duodenal ulcer (3% higher P &lt; 0.001). Of the respondents who had undergone sympathectomy (n = 140, 24.5% of the total), 18.6% claimed lasting benefit and 66.4% claimed no benefit after one year. The mean age at sympathectomy was 38.6 years ( s.d. ± 13 range 14–78) with a mean age of start of symptoms of 29.2 years ( s.d. ± 14.7, range 0–70). There was no significant difference between the effects of sympathectomy on those patients with and those without associated conditions.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Age Factors</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Angina Pectoris - epidemiology</subject><subject>Child</subject><subject>Epidemiology</subject><subject>Female</subject><subject>Fetal Death - complications</subject><subject>Health Surveys</subject><subject>Humans</subject><subject>Infertility - epidemiology</subject><subject>Male</subject><subject>Menopause</subject><subject>Menstrual Cycle</subject><subject>Middle Aged</subject><subject>Migraine Disorders - epidemiology</subject><subject>Pre-Eclampsia - epidemiology</subject><subject>Pregnancy</subject><subject>Raynaud Disease - complications</subject><subject>Raynaud Disease - epidemiology</subject><subject>Raynaud Disease - therapy</subject><subject>Raynaud's phenomenon</subject><subject>Scleroderma</subject><subject>Scleroderma, Systemic - complications</subject><subject>Surveys and Questionnaires</subject><subject>Sympathectomy</subject><issn>0950-821X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1988</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkMlqwzAQhnVoSdO0jxDwqcvB7ci2LPlUQugGgUIX6E3I0rhVsS1XigN5-zoLuXZgGJjtn_kImVK4oUDz2zcoGMQioZ9XQlwLAA4xPyLjQ_qEnIbwA5DyApIRGaUZBcjZmNBZG2FnDTbW1e7LalVHofcrXEeuil7VulW9uQxR942tawZvz8hxpeqA5_s4IR8P9-_zp3jx8vg8ny1inXC2jEtTVSBMWQ4n8HwwzaqUJVRAUmpQghYCKxSFMYalDLOiTCpOIcsYqDRTJp2Qi93ezrvfHsNSNjZorGvVouuD5CLlOSTF0Mh2jdq7EDxWsvO2UX4tKcgNHrnFIzccpBByi0fyYW66F-jLBs1has9mqN_t6jh8ubLoZdAWW43GetRLaZz9R-EPHVh2Rw</recordid><startdate>198806</startdate><enddate>198806</enddate><creator>de Trafford, J.C.</creator><creator>Lafferty, K.</creator><creator>Potter, C.E.</creator><creator>Roberts, V.C.</creator><creator>Cotton, L.T.</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>198806</creationdate><title>An epidemiological survey of Raynaud's phenomenon</title><author>de Trafford, J.C. ; Lafferty, K. ; Potter, C.E. ; Roberts, V.C. ; Cotton, L.T.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c275t-bdff08dbb95076666c5f3521802bc0a8198efe89ddd535e49b2f7104450a34ad3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1988</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Age Factors</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Angina Pectoris - epidemiology</topic><topic>Child</topic><topic>Epidemiology</topic><topic>Female</topic><topic>Fetal Death - complications</topic><topic>Health Surveys</topic><topic>Humans</topic><topic>Infertility - epidemiology</topic><topic>Male</topic><topic>Menopause</topic><topic>Menstrual Cycle</topic><topic>Middle Aged</topic><topic>Migraine Disorders - epidemiology</topic><topic>Pre-Eclampsia - epidemiology</topic><topic>Pregnancy</topic><topic>Raynaud Disease - complications</topic><topic>Raynaud Disease - epidemiology</topic><topic>Raynaud Disease - therapy</topic><topic>Raynaud's phenomenon</topic><topic>Scleroderma</topic><topic>Scleroderma, Systemic - complications</topic><topic>Surveys and Questionnaires</topic><topic>Sympathectomy</topic><toplevel>online_resources</toplevel><creatorcontrib>de Trafford, J.C.</creatorcontrib><creatorcontrib>Lafferty, K.</creatorcontrib><creatorcontrib>Potter, C.E.</creatorcontrib><creatorcontrib>Roberts, V.C.</creatorcontrib><creatorcontrib>Cotton, L.T.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of vascular surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>de Trafford, J.C.</au><au>Lafferty, K.</au><au>Potter, C.E.</au><au>Roberts, V.C.</au><au>Cotton, L.T.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>An epidemiological survey of Raynaud's phenomenon</atitle><jtitle>European journal of vascular surgery</jtitle><addtitle>Eur J Vasc Surg</addtitle><date>1988-06</date><risdate>1988</risdate><volume>2</volume><issue>3</issue><spage>167</spage><epage>170</epage><pages>167-170</pages><issn>0950-821X</issn><abstract>A questionnaire was sent to 1000 patients with Raynaud's phenomenon (RP) and an equal number of controls in order to accumulate one of the largest patient data banks currently available. Five-hundred and seventy-one correctly completed paired returns were processed so as to investigate the association between Raynaud's phenomenon and other factors suspected of influencing the condition. The involvement of female sex hormones in RP was indicated by the predominance of women (93%), a 6% (P &lt; 0.02) higher incidence of infertility and the influence of menstruation (15%), the menopause (73%) and pregnancy (53%) on symptoms. Patients with scleroderma had a 5% higher incidence of stillbirths. A familial predisposition for RP was noted dependent on age at onset of symptoms (age &lt; 30, 14% &gt; 30, 4.9%). The Raynaud's group overall had a significantly higher percentage who had been treated for migraine (7% higher P &lt; 0.01), angina (3% higher P &lt; 0.05) and duodenal ulcer (3% higher P &lt; 0.001). Of the respondents who had undergone sympathectomy (n = 140, 24.5% of the total), 18.6% claimed lasting benefit and 66.4% claimed no benefit after one year. The mean age at sympathectomy was 38.6 years ( s.d. ± 13 range 14–78) with a mean age of start of symptoms of 29.2 years ( s.d. ± 14.7, range 0–70). There was no significant difference between the effects of sympathectomy on those patients with and those without associated conditions.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>3410065</pmid><doi>10.1016/S0950-821X(88)80070-7</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0950-821X
ispartof European journal of vascular surgery, 1988-06, Vol.2 (3), p.167-170
issn 0950-821X
language eng
recordid cdi_proquest_miscellaneous_78376029
source MEDLINE; Alma/SFX Local Collection
subjects Adolescent
Adult
Age Factors
Aged
Aged, 80 and over
Angina Pectoris - epidemiology
Child
Epidemiology
Female
Fetal Death - complications
Health Surveys
Humans
Infertility - epidemiology
Male
Menopause
Menstrual Cycle
Middle Aged
Migraine Disorders - epidemiology
Pre-Eclampsia - epidemiology
Pregnancy
Raynaud Disease - complications
Raynaud Disease - epidemiology
Raynaud Disease - therapy
Raynaud's phenomenon
Scleroderma
Scleroderma, Systemic - complications
Surveys and Questionnaires
Sympathectomy
title An epidemiological survey of Raynaud's phenomenon
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T22%3A15%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=An%20epidemiological%20survey%20of%20Raynaud's%20phenomenon&rft.jtitle=European%20journal%20of%20vascular%20surgery&rft.au=de%20Trafford,%20J.C.&rft.date=1988-06&rft.volume=2&rft.issue=3&rft.spage=167&rft.epage=170&rft.pages=167-170&rft.issn=0950-821X&rft_id=info:doi/10.1016/S0950-821X(88)80070-7&rft_dat=%3Cproquest_cross%3E78376029%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78376029&rft_id=info:pmid/3410065&rft_els_id=S0950821X88800707&rfr_iscdi=true